Juvenile Inflammatory Rheumatism (JIR) Cohorte (JIR-cohorte)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02377245 |
Recruitment Status :
Enrolling by invitation
First Posted : March 3, 2015
Last Update Posted : December 29, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Arthritis, Juvenile Rheumatoid |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 15000 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 10 Years |
Official Title: | Setting up a Pediatric Cohort for Inflammatory Rheumatic Diseases |
Study Start Date : | January 2014 |
Estimated Primary Completion Date : | December 2025 |
Estimated Study Completion Date : | December 2028 |

Group/Cohort |
---|
Juvenile Inflammatory Rheumatism
Juvenile Inflammatory Rheumatism patients
|
- Number of severe and very severe adverse event as a mesure of safety and tolerability [ Time Frame: 10 years ]
- Number of treatments prescribed off label [ Time Frame: 10 Years ]
- Length in months of drug survival in patient treated with at least two consecutive biological agents [ Time Frame: 10 Years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients with juvenile inflammatory diseases
- Age at onset up to 18 years old
- Consent according national codes of ethics and current laws
Exclusion Criteria:
- Non-consent from patients and/or legal representative

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02377245

Study Director: | Michael Hofer | University of Lausanne Hospitals |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Michaël Hofer, Head of Pediatric Rheumatology unit, University of Lausanne Hospitals |
ClinicalTrials.gov Identifier: | NCT02377245 |
Other Study ID Numbers: |
JIR-001 |
First Posted: | March 3, 2015 Key Record Dates |
Last Update Posted: | December 29, 2021 |
Last Verified: | December 2021 |
Juvenile Inflammatory Rheumatism Pediatric-Onset inflammatory diseases |
Arthritis, Juvenile Arthritis Joint Diseases Musculoskeletal Diseases |
Rheumatic Diseases Connective Tissue Diseases Autoimmune Diseases Immune System Diseases |